Drug discovery > Basic Research Products & Reviews

The purification kits are designed to be quick and easy to use and perfect for your downstream applications of choice.

The Chromatrap Gel Purification Kit contains spin columns and reagents to quickly and efficiently purify DNA from agarose gels. Elute high yield and ultra-pure DNA for downstream molecular biological applications.

Clean up and concentrate DNA in as little as 5µl (5-10 µg DNA) elution volume.

Easily purify your preferred DNA fragments from a wide range of sample sources with the Chromatrap Size Selection kit. In 3 simple steps (bind, wash and elute) in under 5 minutes, elute superior quality DNA fragments of your desired size for downstream applications such as library preparation for next generation sequencing in under 5 minutes.

The Chromatrap ChIP-Seq kit is the go-to, high sensitivity kit for low cell ChIP. Whether you are looking at transcription factors or histone modifications, the Chromatrap ChIP-Seq is a robust kit designed to perform faster, easier with no compromise on sensitivity. 

The Chromatrap ChIP-Seq kit is the go-to, high sensitivity kit for low cell ChIP. Whether you are looking at transcription factors or histone modifications, the Chromatrap ChIP-Seq is a robust kit designed to perform faster, easier with no compromise on sensitivity.

The Chromatrap ChIP-Seq kit is the go-to, high sensitivity kit for low cell ChIP. Whether you are looking at transcription factors or histone modifications, the Chromatrap ChIP-Seq is a robust kit designed to perform faster, easier with no compromise on sensitivity.

The Chromatrap ChIP-Seq kit is the go-to, high sensitivity kit for low cell ChIP. Whether you are looking at transcription factors or histone modifications, the Chromatrap ChIP-Seq is a robust kit designed to perform faster, easier with no compromise on sensitivity.

The use of high quality and specific ChIP validated antibodies is essential for the success of a ChIP assay. Chromatrap ® ChIP-validated Antibodies can now be supplied with the correct matching primer sets to cover all aspects of ChIP validation.

Streamline your ChIP and library preparation with the Chromatrap kit that allows you to sequentially perform ChIP and library preparation for next-generation sequencing.  

The success of a ChIP assay is highly dependent on the quality of chromatin prepared. Chromatrap® supply individual reagents for the isolation of chromatin from your sample.  

The use of high quality and specific ChIP validated antibodies is essential for the success of a ChIP assay. Chromatrap provides a range of popular ChIP validated antibodies.

The first dedicated ChIP-Seq and library preparation kit for Drosophila.

Heat Seals for Microplates

Mats and Caps for Microplates

24 Well Clear Assay Microplate

96 Well Clear Assay Microplate

Robotic Friendly Manifold

Maximum protein recovery

Low autofluorescence and optimum gas exchange

OXM causes weight loss via suppression of food intake and increase in energy expenditure. OXM administration was also reported to increase heart-rate in mice. Besides regulating glucose homeostasis in monogastric animals, OXM also increases the concentration of insulin and glucose in plasma of Holstein cattle under normal physiological conditions. It has been shown that Type 2 diabetes patients have lower levels of OXM and lev…

The Ansh Labs Bioactive IGF-I kit uses a highly sensitive two-site antibody method which allows detection of bioactive IGF-I. This assay enables accurate measurement and differentiation of bioactive IGF-I from total IGF-I levels. Assessment of bioactive to total IGF-I ratio will be informative and advance our understanding of IGF-I function and regulation in different physiological and disease states.

The Total IGF-I immunoassay is a direct detection method which eliminates potential altering of sample matrix from size-exclusion chromatography or filtration methods.  

The ratio of Total to Intact IGFBP-4 concentration measured in individual subjects over time will help normalizes the IGFBP-4 variability between subjects and also increase the detection rate of increased PAPP-A activity in myocardial infarction subjects.

During pregnancy, PAPP-A is produced in high concentrations by the trophoblast and released into maternal circulation. In addition to trophoblasts, PAPP-A expression has been reported in various tissues, including endometrium, testis, atherosclerotic arteries, kidney, bone, colon, and other adult and fetal tissue.